Jean-Claude Chermann - Publications

Affiliations: 
Institut Pasteur, Paris, Paris, France 
Area:
Virology
Website:
http://fr.wikipedia.org/wiki/Jean-Claude_Chermann

235 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Chermann JF, Savigny A, Radafy A, Blandin N, Bohu Y. Sports-related concussion in elite athletes: Prospective study of 211 cases seen in a specialized outpatient clinic Journal De Traumatologie Du Sport. DOI: 10.1016/j.jts.2015.12.008  0.199
2016 Radafy A, Vesselle B, Frey A, Sene JM, Quiniou Y, Chermann JF. Concussion and strangulation in the high-level judo: 75 judokas | Commotion cérébrale et étranglement dans le judo de haut niveau: 75 judokas Journal De Traumatologie Du Sport. 33: 4-13. DOI: 10.1016/j.jts.2015.12.003  0.19
2014 Chermann JF, Klouche S, Savigny A, Lefevre N, Herman S, Bohu Y. Return to rugby after brain concussion: A prospective study in 35 high level rugby players Asian Journal of Sports Medicine. 5. DOI: 10.5812/asjsm.24042  0.182
2014 Chermann JF. Brain concussion and sport, long-term complications | Commotions cérébrales et sport: complications à long terme Journal De Readaptation Medicale. 34: 118-125. DOI: 10.1016/j.jrm.2014.06.007  0.18
2012 Vidalin H, Chermann JF, Stiernon T, Valy G. Brain concussion in sport | Commotion cérébrale et sport Science and Sports. 27: 382-390. DOI: 10.1016/j.scispo.2012.10.004  0.182
2011 Bouhlal R, Haslin C, Chermann JC, Colliec-Jouault S, Sinquin C, Simon G, Cerantola S, Riadi H, Bourgougnon N. Antiviral activities of sulfated polysaccharides isolated from Sphaerococcus coronopifolius (Rhodophytha, Gigartinales) and Boergeseniella thuyoides (Rhodophyta, Ceramiales) Marine Drugs. 9: 1187-1209. PMID 21822410 DOI: 10.3390/md9071187  0.465
2011 Decq P, Chermann JF, Loiseau H, Pariente J, Touchon J, Mias L, Vidalin H, Lagarrigue J. Professional rugby and head injury (Concussions): Guidelines for their management in France | Rugby professionnel et traumatismes crâniens (commotions cérébrales): recommandations pour leur prise en charge en France Journal De Traumatologie Du Sport. 28: 227-242. DOI: 10.1016/j.jts.2011.10.005  0.18
2010 Vidalin H, Chermann JF, Stiernon T, Valy G, Savigny A, Duclos M, Dionet E, Privat A, Chazal J. Commotio cerebri and sports | Les commotions cérébrales et le sport Journal De Traumatologie Du Sport. 27: 83-93. DOI: 10.1016/j.jts.2010.04.007  0.188
2008 Tuleja E, Chermann JF, Séréni C, Hart G, Séréni D. Klüver Bucy syndrome, unusual consequence of excessively rapid correction of severe hyponatremia Presse Medicale. 37: 975-977. PMID 18375096 DOI: 10.1016/j.lpm.2007.08.021  0.233
2008 Barré-Sinoussi F, Chermann JC, Montagnier L. 25 Years ago in immunology Scientist. 22: 64.  0.656
2007 Haslin C, Lévêque M, Ozil A, Cérutti P, Chardès T, Chermann JC, Duonor-Cérutti M. A recombinant human monoclonal anti-R7V antibody as a potential therapy for HIV infected patients in failure of HAART Human Antibodies. 16: 73-85. PMID 18334743  0.422
2005 Chermann JF, Caillon É. Relational medical aesthetics | L'esthétique relationnelle médicale Evolution Psychiatrique. 70: 177-185. DOI: 10.1016/j.evopsy.2004.11.004  0.185
2004 Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Revista De Investigacion Clinica. 56: 126-129. PMID 15378805  0.706
2002 Xu X, Xing H, Gong W, Chen H, Si C, Wang Y, Chermann JC. [Preliminary investigation on the relation between clinical progress and anti-small monomolecular peptides antibody in individual infected with HIV]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 16: 286-7. PMID 12665943  0.394
2002 Haslin C, Chermann JC. Anti-R7V antibodies as therapeutics for HIV-infected patients in failure of HAART Current Opinion in Biotechnology. 13: 621-624. PMID 12482524 DOI: 10.1016/S0958-1669(02)00381-6  0.439
2002 Rocheblave L, Bihel F, De Michelis C, Priem G, Courcambeek J, Bonnet B, Chermann JC, Kraus JL. Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres Journal of Medicinal Chemistry. 45: 3321-3324. PMID 12109915 DOI: 10.1021/jm0208323  0.399
2002 Chermann JF, Chedan F, Lermuzeaux C, Abert MO, Séréni C. Identity amnesia, focal retrograde amnesia arising during the decline phase of a slight head injury: A study of two clinical cases | Amnésie d'identité et amnésie rétrograde focale survenues au décours d'un traumatisme crânien léger: À propos de deux cas cliniques Evolution Psychiatrique. 67: 207-222. DOI: 10.1016/S0014-3855(02)00112-3  0.184
2002 Chermann JF, Ziegler M, Sereni C. Partial epilepsy followed by generalized epilepsy | Une éilepsie partielle puis généralisée Revue Du Praticien - Medecine Generale. 16: 1863.  0.178
2001 Chermann JC. A brief reflection on the development of human retrovirology: the past, the present and the future. Journal of Human Virology. 4: 289-95. PMID 12082395  0.225
2001 Chermann JF. Anatomy and symptomatology of the spinal cord | Anatomie et sémiologie élémentaires de la moelle épinière Revue Du Praticien. 51: 1176-1179. PMID 11503485  0.173
2001 Haslin C, Lahaye M, Pellegrini M, Chermann JC. In vitro anti-HIV activity of sulfated cell-wall polysaccharides from gametic, carposporic and tetrasporic stages of the Mediterranean red alga Asparagopsis armata Planta Medica. 67: 301-305. PMID 11458443 DOI: 10.1055/s-2001-14330  0.438
2001 Vlieghe P, Bihel F, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Chermann JC, Kraus JL. New 3′-azido-3′-deoxythymidin-5′-yl O-(ω-hydroxyalkyl) carbonate prodrugs: Synthesis and anti-HIV evaluation Journal of Medicinal Chemistry. 44: 777-786. PMID 11262088 DOI: 10.1021/jm001033s  0.325
2000 Xu X, Chen L, Wang Q, Chermann JC. Research of status of provirus HIV DNA in non-progressor and progressor of HIV-1 infected persons Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology. 14: 333-337. PMID 11471019  0.393
2000 Mourier N, Camplo M, Della Bruna GS, Pellacini F, Ungheri D, Chermann JC, Kraus JL. Synthesis and anti-HIV evaluation of new 2',3'-dideoxy-3'-thiacytidine prodrugs Nucleosides, Nucleotides and Nucleic Acids. 19: 1057-1091. PMID 10999248 DOI: 10.1080/15257770008035031  0.372
2000 Kraus JL, Bouygues M, Courcambeck J, Chermann JC. Use of proline bioisosteres in potential HIV protease inhibitors: Phenylalanine-2-thiophenoxy-3-pyrrolidinone: Synthesis and anti-HIV evaluation Bioorganic and Medicinal Chemistry Letters. 10: 2023-2026. PMID 10987441 DOI: 10.1016/S0960-894X(00)00393-0  0.408
2000 De Michelis C, Rocheblave L, Priem G, Chermann JC, Kraus JL. New anti-HIV derivatives: Synthesis and antiviral evaluation Bioorganic and Medicinal Chemistry. 8: 1253-1262. PMID 10896105 DOI: 10.1016/S0968-0896(00)00055-9  0.392
1999 Medou M, Priem G, Rocheblave L, Pepe G, Meyer M, Chermann JC, Kraus JL. Synthesis and anti-HIV activity of α-thiophenoxy-hydroxyethylamide derivatives European Journal of Medicinal Chemistry. 34: 625-638. PMID 11278047  0.389
1999 Godard CM, Chermann JC. Experimental conditions that increase the production of HIV-1 by monocyte-derived macrophages: Use of collagen matrix Microbes and Infection. 1: 765-770. PMID 10816081 DOI: 10.1016/S1286-4579(99)80078-1  0.382
1999 Bergé JP, Bourgougnon N, Alban S, Pojer F, Billaudel S, Chermann JC, Robert JM, Franz G. Antiviral and anticoagulant activities of a water-soluble fraction of the marine diatom Haslea ostrearia. Planta Medica. 65: 604-9. PMID 10575374 DOI: 10.1055/s-1999-14032  0.336
1999 Dessolin J, Galéa P, Vliegne P, Chermann JC, Kraus JL. New polyazamacrocycle-nucleoside conjugates: Synthesis, anti-HIV evaluation and interaction with CXCR-4 coreceptor Nucleosides and Nucleotides. 18: 881-882. PMID 10432701  0.321
1999 Camplo M, Mourier N, Chermann JC, Kraus JL. Synthesis and biological evaluation of polyaminated 2',3'-dideoxy-3'- thiacytidine prodrugs Nucleosides and Nucleotides. 18: 879-880. PMID 10432700  0.298
1999 Klein JLD, Roberts JD, George MD, Kurtzberg J, Breton P, Chermann JC, Olden K. Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity British Journal of Cancer. 80: 87-95. PMID 10389983 DOI: 10.1038/sj.bjc.6690326  0.268
1999 Galéa P, Le Contel C, Chermann JC. A novel epitope R7V common to all HIV-1 isolates is recognized by neutralizing IgG found in HIV-infected patients and immunized rabbits Vaccine. 17: 1454-1461. PMID 10195781 DOI: 10.1016/S0264-410X(98)00374-0  0.422
1999 Galéa P, Le Contel C, Coutton C, Chermann JC. Rationale for a vaccine using cellular-derived epitope presented by HIV isolates Vaccine. 17: 1700-1705. PMID 10194825 DOI: 10.1016/S0264-410X(98)00432-0  0.4
1999 Dessolin J, Galea P, Vlieghe P, Chermann JC, Kraus JL. New bicyclam-AZT conjugates: Design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor Journal of Medicinal Chemistry. 42: 229-241. PMID 9925728 DOI: 10.1021/jm980358u  0.39
1999 Chermann JF. MR imaging of acute visual loss revealed multiple sclerosis | Une baisse brutale de l'acuite visuelle Revue Du Praticien - Medecine Generale. 13: 1845.  0.191
1999 Chermann JF. A professor beyond reproach with Creutzfeldt-Jakob disease | Un professeur qui n'avait jamais ete chahute: Maladie de Creutzfeldt- Jakob Revue Du Praticien - Medecine Generale. 13: 1161.  0.189
1999 Chermann JF. Un professeur jamais chahuté Revue Du Praticien - Medecine Generale. 13: 1161.  0.266
1999 Chermann JF. Délinquance et maladie de Huntington Revue Du Praticien - Medecine Generale. 13: 968.  0.183
1999 Chermann JF. Céphalées déclenchées par l'usage répété des triptans Revue Du Praticien - Medecine Generale. 13: 967.  0.18
1999 Chermann JF. Survenue d'un talent artistique chez des patients atteints de démence fronto-temporale Revue Du Praticien - Medecine Generale. 13: 638-639.  0.212
1998 Galéa P, Chermann JC. HIV as the cause of AIDS and associated diseases Genetica. 104: 133-142. PMID 10220906 DOI: 10.1023/A:1003432603348  0.372
1998 Galea P, Frances V, Dou-Dameche L, Sampol J, Chermann JC. Role of Kaposi's sarcoma cells in recruitment of circulating leukocytes: Implications in pathogenesis Journal of Human Virology. 1: 273-281. PMID 10195252  0.238
1998 Godard CM, Chermann JC. Stimulation of bystander T-Cell proliferation by tumor necrosis factor produced by HIV-1-infected macrophages Journal of Human Virology. 1: 257-266. PMID 10195250  0.367
1998 Trabaud C, Dessolin J, Camplo M, Hantz O, Zoulim F, Borel C, Meyer M, Pepe G, Chermann JC, Kraus JL. Design, synthesis and structure relationships of new N,N',N'',N'''-tetrakis (ω-amino alkyl) tetraazamacrocycles Antiviral Chemistry and Chemotherapy. 9: 73-84. PMID 9875379  0.331
1998 Medou M, Bouygues M, Rocheblave L, Chermann JC, Kraus JL. Synthesis and anti-HIV activities of symmetrical N1,N3-dibenzyl-2- hydroxy-propane derivatives Bioorganic and Medicinal Chemistry Letters. 8: 1861-1866. PMID 9873448 DOI: 10.1016/S0960-894X(98)00323-0  0.353
1998 Bouygues M, Medou M, Quéléver G, Chermann JC, Camplo M, Kraus JL. Syntheses of new modified Phe-Pro peptides. Use of proline replacements in potential HIV inhibitors Bioorganic and Medicinal Chemistry Letters. 8: 277-280. PMID 9871669 DOI: 10.1016/S0960-894X(98)00006-7  0.345
1998 Chenine AL, Matouskova E, Sanchez G, Reischig J, Pavlikova L, LeContel C, Chermann JC, Hirsch I. Primary intestinal epithelial cells can be infected with laboratory- adapted strain HIV type 1 NDK but not with clinical primary isolates Aids Research and Human Retroviruses. 14: 1235-1238. PMID 9764906  0.407
1998 Chermann JC. Sexual and mother-to-child transmission of the human immunodeficiency virus type 1: A review American Journal of Reproductive Immunology. 40: 183-186. PMID 9764363  0.341
1998 Dessolin J, Vlieghe P, Bouygues M, Medou M, Quéléver G, Camplo M, Chermann JC, Kraus JL. Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: Synthesis and anti- HIV activities Nucleosides and Nucleotides. 17: 957-968. PMID 9708333 DOI: 10.1080/07328319808003466  0.358
1998 Bouygues M, Medou M, Chermann JC, Camplo M, Kraus JL. Short and unexpectedly potent 3-pyrrolidinone type inhibitors of HIV-1 replication European Journal of Medicinal Chemistry. 33: 445-450. DOI: 10.1016/S0223-5234(98)80045-7  0.407
1997 Machado AA, Hirsch I, Figueiredo JF, Martinez R, Chermann JC. Neutralizing antibodies in Brazilian sera against three strains of human immunodeficiency virus type 1 (HIV-1). Revista Do Instituto De Medicina Tropical De SãO Paulo. 39: 319-22. PMID 9674281  0.441
1997 Godard CM, Serriès H, Fulachier C, Chermann JC. Apoptosis of CD4+ T cells induced after contact with HIV1-infected or non-infected macrophages Research in Virology. 148: 383-396. PMID 9498010 DOI: 10.1016/S0923-2516(97)83628-X  0.389
1997 Brechard N, Galea P, Silvy F, Amram M, Chermann JC. HIV detection in seropositive male ejaculation at different times | Recherche du virus VIH dans des ejaculats recueillis a des temps variables de sujets seropositifs Contraception Fertilite Sexualite. 25: 725-729. PMID 9410396  0.413
1997 Coutton C, Chermann JC. In vitro study of seraspenide on HIV-induced inhibition of granulopoiesis European Journal of Haematology. 59: 184-189. PMID 9310127  0.402
1997 Brechard N, Galea P, Silvy F, Amram M, Chermann JC. Study of HIV localization in sperm | Etude de la localisation du VIH dans le sperme Contraception Fertilite Sexualite. 25: 389-391. PMID 9273111  0.395
1997 Galea P, Vermot-Desroches C, Le Contel C, Wijdenes J, Chermann JC. Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression Research in Immunology. 148: 109-117. PMID 9226765 DOI: 10.1016/S0923-2494(97)82482-0  0.381
1997 Sanchez G, Xu X, Chermann JC, Hirsch I. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals Journal of Virology. 71: 2233-2240. PMID 9032358  0.411
1997 Chermann JC, Kraus JL, Camplo M. HIV reverse transcriptase (RT) and HIV protease inhibitors Expert Opinion On Therapeutic Targets. 1: 55-57. DOI: 10.1517/14728222.1.1.55  0.385
1997 Trabaud C, Dessolin J, Vlieghe P, Bouygues M, Chermann JC, Camplo M, Kraus JL. Modelisation, synthesis and anti-HIV activities of N,N,N',N',N'-pentakis-tetraazamacrocycles salts derivatives Bioorganic and Medicinal Chemistry Letters. 7: 1353-1358. DOI: 10.1016/S0960-894X(97)00222-9  0.321
1997 Sondhi SM, Verma RP, Sharma VK, Singhal N, Kraus JL, Camplo M, Chermann JC. Synthesis and anti-HIV screening of some heterocyclic compounds Phosphorus, Sulfur and Silicon and Related Elements. 122: 215-225.  0.343
1996 Machado AA, Hirsch I, Figueiredo JF, Martinez R, de Freitas-Silva G, Chermann JC, Covas DT. Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) | Ocorrência de falso positivo em testes com peptídeos sintéticos para pesquisa de anticorpos contra o vírus da imunodeficiência humana tipo 2 (HIV-2) em pacientes brasileiros infectados pelo vírus da imunodeficiência humana tipo 1 (HIV-1). Revista Da Sociedade Brasileira De Medicina Tropical. 29: 615-617. PMID 9011891  0.443
1996 Mûri RM, Chermann JF, Cohen L, Rivaud S, Pierrot-Deseilligny C. Ocular motor consequences of damage to the abducens nucleus area in humans Journal of Neuro-Ophthalmology. 16: 191-195. PMID 8865013  0.2
1996 Hirsch I, De Mareuil J, Salaun D, Chermann JC. Genetic control of infection of primary macrophages with T-cell-tropic strains of HIV-1 Virology. 219: 257-261. PMID 8623536 DOI: 10.1006/viro.1996.0243  0.454
1996 Graciet JC, Niddam V, Gamberoni M, Trabaud C, Dessolin J, Medou M, Mourier N, Zoulim F, Borel C, Hantz O, Camplo M, Chermann JC, Kraus JL. Modelisation, synthesis and antiviral evaluation of new 2,3-disubstituted thiazolidinone nucleoside analogues Bioorganic and Medicinal Chemistry Letters. 6: 1775-1780. DOI: 10.1016/0960-894X(96)00316-2  0.335
1996 Niddam V, Camplo M, Le Nguyen D, Chermann JC, Kraus JL. Thiophenoxy peptides : A new class of HIV replication inhibitors Bioorganic and Medicinal Chemistry Letters. 6: 609-614. DOI: 10.1016/0960-894X(96)00085-6  0.335
1996 Camplo M, Charvet-Faury AS, Borel C, Turin F, Hantz O, Trabaud C, Niddam V, Mourier N, Graciet JC, Chermann JC, Kraus JL. Synthesis and antiviral activity of N-4'-dihydropyridinyl and dihydroquinolinylcarbonyl-2-hydroxymethyl-5-[cytosin-1'-yl]-1, 3-oxathiolane derivatives against human immunodeficiency virus and duck hepatitis B virus European Journal of Medicinal Chemistry. 31: 539-546. DOI: 10.1016/0223-5234(96)89550-X  0.301
1996 Pèpe G, Meyer M, Faury P, Graciet JC, Chermann JC, Kraus JL. A model allowing the design of modified nucleosides as HIV-RT inhibitors European Journal of Medicinal Chemistry. 31: 775-786. DOI: 10.1016/0223-5234(96)83971-7  0.356
1996 Liu JN, Zhang DZ, Chen YH, Gurewich V, Chermann JC. Urokinase (uk) inhibits infecttvity by common north american strains of hiv-1 Fibrinolysis. 10: 10.  0.358
1996 Bourgougnon N, Lahaye M, Quemener B, Chermann JC, Rimbert M, Cormaci M, Furnari G, Kornprobst JM. Annual variation in composition and in vitro anti-HIV-1 activity of the sulfated glucuronogalactan from Schizymenia dubyi (Rhodophyta, Gigartinales) Journal of Applied Phycology. 8: 155-161.  0.37
1996 Mourier N, Trabaud C, Niddam V, Graciet JC, Camplo M, Chermann JC, Kraus JL. Synthesis and anti-HIV evaluation of new 5-substituted-2',3'-dideoxy- 3'-thiauridine nucleosides Nucleosides and Nucleotides. 15: 1397-1409.  0.367
1995 De Mareuil J, Salaun D, Chermann JC, Hirsch I. Fusogenic determinants of highly cytopathic subtype D Zairian isolate HIV- 1 NDK Virology. 209: 649-653. PMID 7778297 DOI: 10.1006/viro.1995.1298  0.437
1995 Hammar L, Hirsch I, Machado AA, De Mareuil J, Baillon JG, Bolmont C, Chermann JC. Lectin-mediated effects on HIV type 1 infection in vitro Aids Research and Human Retroviruses. 11: 87-95. PMID 7734200  0.443
1995 Artioli Machado A, Bakpabua M, Salaun D, de Mareuil J, Krchnak V, MacGregor RR, Chermann JC, Hirsch I. Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa Vaccine. 13: 321-325. PMID 7631521 DOI: 10.1016/0264-410X(95)93321-Y  0.438
1995 Calenda V, Chermann JC. HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth European Journal of Haematology. 54: 180-185. PMID 7536687  0.406
1995 Divita G, Baillon JG, Rittinger K, Chermann JC, Goody RS. Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors Journal of Biological Chemistry. 270: 28642-28646. PMID 7499382 DOI: 10.1074/jbc.270.48.28642  0.366
1995 Camplo M, Niddam V, Barthélémy P, Faury P, Mourier N, Simon V, Charvet AS, Trabaud C, Graciet JC, Chermann JC, Kraus JL. Synthesis and anti-human immunodeficiency virus type 1 activities of new peptido-nucleoside analogues European Journal of Medicinal Chemistry. 30: 789-800. DOI: 10.1016/0223-5234(96)88298-5  0.409
1995 Mourier N, Trabaud C, Graciet JC, Simon V, Niddam V, Faury P, Charvet AS, Camplo M, Chermann JC, Kraus JL. Peptide-nucleoside conjugates: Synthesis and anti-HIV activities Nucleosides and Nucleotides. 14: 1393-1402.  0.348
1994 Calenda V, Graber P, Delamarter JF, Chermann JC. Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: In vitro study on bone marrow progenitor cells European Journal of Haematology. 52: 103-107. PMID 8119379  0.41
1994 Charvet AS, Camplo M, Faury P, Graciet JC, Mourier N, Chermann JC, Kraus JL. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2′,3′-dideoxy-3′-thiacytidine conjugates Journal of Medicinal Chemistry. 37: 2216-2223. PMID 8035429 DOI: 10.1021/Jm00040A014  0.372
1994 Hammar L, Hirsch I, Machado A, De Mareuil J, Baillon J, Chermann JC. Lectin effects on HIV-1 infectivity Annals of the New York Academy of Sciences. 724: 166-169. PMID 8030938 DOI: 10.1111/j.1749-6632.1994.tb38907.x  0.42
1994 Cohen L, Bolgert F, Timsit S, Chermann JF. Anomia for proper names after left thalamic infarct Journal of Neurology, Neurosurgery and Psychiatry. 57: 1283-1284. PMID 7931410 DOI: 10.1136/jnnp.57.10.1283  0.164
1994 Relyveld E, Chermann JC. Humoral response in rabbits immunized with calcium phosphate adjuvanted HIV-1 gp160 antigen Biomedicine and Pharmacotherapy. 48: 79-83. PMID 7919109 DOI: 10.1016/0753-3322(94)90080-9  0.344
1994 Lazarini F, Castelnau P, Chermann JF, Deslys JP, Dormont D. Modulation of prion protein gene expression by growth factors in cultured mouse astrocytes and PC-12 cells Molecular Brain Research. 22: 268-274. PMID 7912403 DOI: 10.1016/0169-328X(94)90055-8  0.208
1994 Charvet AS, Turin F, Faury P, Hantz O, Camplo M, Mourier N, Berthillon P, Graciet JC, Chermann JC, Trépo C, Kraus JL. Synthesis and antiviral activity of new carbonylphosphonate 2′,3′-dideoxy-3′-thiacytidine conjugates Antiviral Research. 25: 161-168. PMID 7847877 DOI: 10.1016/0166-3542(94)90104-X  0.397
1994 Divita G, Restle T, Goody RS, Chermann JC, Baillon JG. Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain Journal of Biological Chemistry. 269: 13080-13083. PMID 7513698  0.34
1994 Camplo M, Faury P, Charvet A, Graciet J, Chermann J, Kraus J. Synthesis and comparative anti-HIV activities of new acetylated 2′,3′-dideoxy-3′-thiacytidine analogues European Journal of Medicinal Chemistry. 29: 357-362. DOI: 10.1016/0223-5234(94)90060-4  0.383
1993 Schmidtmayerova H, Gayet O, Guettari N, Bolmont C, Hirsch I, Chermann JC. Characterization of HIV1-PAR, a macrophage-tropic strain: cell tropism, virus/cell entry and nucleotide sequence of the envelope glycoprotein Research in Virology. 144: 21-26. PMID 8446773 DOI: 10.1016/S0923-2516(06)80007-5  0.43
1993 Tsunetsugu-Yokota Y, Ohshima M, Naito A, Chermann JC, Shih J, Yoshikura H. New HIV plaque titration; application to the assay of neutralizing antibody Journal of Virological Methods. 41: 47-57. PMID 8432763 DOI: 10.1016/0166-0934(93)90162-K  0.476
1993 Calenda V, Silvy F, Chermann JC. Effects of thymus humoral factor gamma-2 (THFγ2) on lymphohaematopoietic progenitor cells: An in vitro study Research in Immunology. 144: 395-406. PMID 8303059 DOI: 10.1016/0923-2494(93)80123-G  0.385
1993 Wondrak EM, Louis JM, de Rocquigny H, Chermann JC, Roques BP. The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins Febs Letters. 333: 21-24. PMID 8224164 DOI: 10.1016/0014-5793(93)80367-4  0.295
1993 Benzair AB, Hirsch I, Chermann JC. Evidence that membrane proteins of rhabdomyosarcoma cell line RD bind human immunodeficiency virus type 1 (HIV-1) Cancer Letters. 73: 113-119. PMID 8221622 DOI: 10.1016/0304-3835(93)90252-5  0.43
1993 Guettari N, Silvy F, Tamalet C, Sauvalgo S, Perrimond H, Michel G, Thuret I, De Boisse P, Leclaire M, Blanc B, Martin-Laval A, Teoule R, Chermann JC. Modified nested polymerase chain reaction for the detection of HIV-1 infection in children [2] Aids. 7: 1269-1271. PMID 8216988  0.343
1993 Sauvaigo S, Barlet V, Guettari N, Innocenti P, Parmentier F, Bastard C, Seigneurin JM, Chermann JC, Teoule R, Marchand J. Standardized nested polymerase chain reaction-based assay for detection of human immunodeficiency virus type 1 DNA in whole blood lysates Journal of Clinical Microbiology. 31: 1066-1074. PMID 8099081  0.414
1993 Benzair AB, Hirsch I, Chermann JC. Binding of human immunodeficiency virus type-1 (HIV-1) to partially purified membrane vesicles of lymphoblastoid cell line CEM Journal of Virological Methods. 45: 319-330. PMID 7508945 DOI: 10.1016/0166-0934(93)90116-9  0.38
1993 Camplo M, Faury P, Charvet AS, Lederer F, Chermann JC, Kraus JL. Synthesis and biological evaluation of a new N4-(N-formyl peptide)- 2',3'-dideoxy-3'-thiacytidine as anti-HIV prodrug Nucleosides and Nucleotides. 12: 631-641. DOI: 10.1080/07328319308019017  0.323
1993 Bourgougnon N, Lahaye M, Chermann JC, Kornprobst JM. Composition and antiviral activities of a sulfated polysaccharide from schizymenia dubyi (rhodophyta, gigartinales) Bioorganic and Medicinal Chemistry Letters. 3: 1141-1146. DOI: 10.1016/S0960-894X(00)80303-0  0.228
1992 Calenda V, Sebahoun G, Chermann JC. Modulation of normal human erythropoietic progenitor cells in long-term liquid cultures after HIV-1 infection. Aids Research and Human Retroviruses. 8: 61-7. PMID 1736941  0.425
1992 Hirsch I, Salaun D, Brichacek B, Chermann JC. HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect. Virology. 186: 647-54. PMID 1733106 DOI: 10.1016/0042-6822(92)90031-J  0.416
1992 Fantini J, Yahi N, Baghdiguian S, Chermann JC. Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion. Journal of Virology. 66: 580-5. PMID 1727501  0.434
1992 Yahi N, Fantini J, Hirsch I, Chermann JC. Structural variability of env and gag gene products from a highly cytopathic strain of HIV-1 Archives of Virology. 125: 287-298. PMID 1642554 DOI: 10.1007/BF01309645  0.411
1992 Calenda V, Chermann JC. The effects of HIV on hematopoiesis. European Journal of Haematology. 48: 181-6. PMID 1592096  0.436
1992 Chermann JC, Fantini J, Calenda V, Silvy F, Hirsch I. Special lectures VIII. AIDS. Aids Research and Human Retroviruses. 8: 711-718. PMID 1515221  0.299
1992 Venaud S, Yahi N, Fehrentz JL, Guettari N, Nisato D, Hirsch I, Chermann JC. Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication. Research in Virology. 143: 311-9. PMID 1480823 DOI: 10.1016/S0923-2516(06)80119-6  0.455
1992 Arthur LO, Bess JW, Sowder RC, Benveniste RE, Mann DL, Chermann JC, Henderson LE. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (New York, N.Y.). 258: 1935-8. PMID 1470916  0.407
1992 Fehrentz JA, Chomier B, Bignon E, Venaud S, Chermann JC, Nisato D. Statine based tripeptides as potent inhibitors of HIV-1 replication Biochemical and Biophysical Research Communications. 188: 873-878. PMID 1445328 DOI: 10.1016/0006-291X(92)91137-F  0.404
1992 Fehrentz JA, Chomier B, Bignon E, Venaud S, Chermann JC, Nisato D. HIV-1 protease inhibitors containing statine : Inhibitory potency and antiviral activity Biochemical and Biophysical Research Communications. 188: 865-872. PMID 1445327 DOI: 10.1016/0006-291X(92)91136-E  0.388
1992 Calenda V, Chermann JC. Severe in vitro inhibition of erythropoiesis and transient stimulation of granulopoiesis after bone-marrow infection with eight different HIV-2 isolates. Aids (London, England). 6: 943-8. PMID 1388905  0.386
1992 Calenda V, Tamalet C, Chermann JC. Transient stimulation of granulopoiesis and drastic inhibition of erythropoiesis in HIV-2-infected long-term liquid bone marrow cultures. Journal of Acquired Immune Deficiency Syndromes. 5: 1148-57. PMID 1383491  0.424
1992 Schmidtmayerova H, Bolmont C, Baghdiguian S, Hirsch I, Chermann JC. Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages. Virology. 190: 124-33. PMID 1382338 DOI: 10.1016/0042-6822(92)91198-4  0.436
1992 Yahi N, Fantini J, Chermann JC. Infection of HIV-1 and HIV-2 through the luminal and serosal sides of polarized human intestinal epithelial cells. Aids (London, England). 6: 335-6. PMID 1373628  0.391
1992 De Mareuil J, Brichacek B, Salaun D, Chermann JC, Hirsch I. The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain Journal of Virology. 66: 6797-6801. PMID 1357191  0.43
1992 Brichacek B, Derderian C, Chermann JC, Hirsch I. HIV-1 infectivity of human carcinoma cell lines lacking CD4 receptors Cancer Letters. 63: 23-31. PMID 1313332 DOI: 10.1016/0304-3835(92)90085-A  0.425
1992 Chermann JF, Miaux Y, Migaud I, Gerber F, Hirsch A. The value of nuclear magnetic resonance in the detection of intermedullary metastasis in a case of epidermoid carcinoma of the bronchus | INTERET DE L'IRM DANS LA DETECTION DE METASTASE INTRAMEDULLAIRE D'UN CARCINOME EPIDERMOIDE BRONCHIQUE Revue Des Maladies Respiratoires. 9: 636-637.  0.188
1991 Zachar V, Nørskov-Lauritsen N, Juhl C, Spire B, Chermann JC, Ebbesen P. Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. The Journal of General Virology. 72: 1253-60. PMID 2045791 DOI: 10.1099/0022-1317-72-6-1253  0.423
1991 Chermann JC, Donker G, Yahi N, Salaun D, Guettari N, Gayet O, Hirsh I. Discrepancies in AIDS virus data. Nature. 351: 277-8. PMID 2034272 DOI: 10.1038/351277b0  0.377
1991 Mano H, Chermann JC. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. Aids Research and Human Retroviruses. 7: 83-8. PMID 2015116  0.442
1991 Guo HG, Chermann JC, Waters D, Hall L, Louie A, Gallo RC, Streicher H, Reitz MS, Popovic M, Blattner W. Sequence analysis of original HIV-1. Nature. 349: 745-6. PMID 2000145 DOI: 10.1038/349745A0  0.362
1991 Mano H, Chermann JC. Replication of human immunodeficiency virus type 1 in primary cultured placental cells. Research in Virology. 142: 95-104. PMID 1896650 DOI: 10.1016/0923-2516(91)90044-4  0.427
1991 Yahi N, Fantini J, Baghdiguian S, Chermann JC. Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity. Journal of Virological Methods. 34: 193-207. PMID 1725173 DOI: 10.1016/0166-0934(91)90099-L  0.406
1991 Mosborg-Petersen P, Toth FD, Zachar V, Villadsen JA, Nørskov-Lauritsen N, Aboagye-Mathiesen G, Chermann JC, Ebbesen P. Differential HIV replication and HIV-induced interferon production in mononuclear phagocytes: relationship to cell maturation. Research in Virology. 142: 353-61. PMID 1722899 DOI: 10.1016/0923-2516(91)90002-K  0.416
1991 Fantini J, Baghdiguian S, Yahi N, Chermann JC. Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells. Virology. 185: 904-7. PMID 1720592 DOI: 10.1016/0042-6822(91)90570-2  0.426
1991 Poncelet P, Poinas G, Corbeau P, Devaux C, Tubiana N, Muloko N, Tamalet C, Chermann JC, Kourilsky F, Sampol J. Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease. Research in Immunology. 142: 291-8. PMID 1718020 DOI: 10.1016/0923-2494(91)90078-W  0.328
1991 Fantini J, Yahi N, Chermann JC. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 88: 9297-301. PMID 1718004  0.427
1991 Robert V, Resnicoff M, Chermann JC, Devaux C. Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1. Molecular and Cellular Biochemistry. 102: 115-23. PMID 1715507 DOI: 10.1007/BF00234569  0.446
1991 Zachar V, Spire B, Hirsch I, Chermann JC, Ebbesen P. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. Journal of Virology. 65: 2102-7. PMID 1705998  0.444
1991 Rey F, Donker G, Hirsch I, Chermann JC. Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies. Virology. 181: 165-71. PMID 1704655 DOI: 10.1016/0042-6822(91)90481-P  0.418
1991 Tsunetsugu-Yokota Y, Tatsumi M, Robert V, Devaux C, Spire B, Chermann JC, Hirsch I. Expression of an immunogenic region of HIV by a filamentous bacteriophage vector. Gene. 99: 261-5. PMID 1673667 DOI: 10.1016/0378-1119(91)90136-Y  0.425
1991 Zachar V, Spire B, Nørskov-Lauritsen N, Chermann JC, Ebbesen P. Cultured trophoblastic choriocarcinoma cells differentially express HIV-1 and cloned provirus. Aids (London, England). 5: 457-8. PMID 1647791  0.356
1991 Rey F, Donker G, Spire B, Devaux C, Chermann JC. Selection of an HIV-1 variant following anti-CD4 treatment of infected cells Aids-Forschung. 6: 243-246.  0.366
1991 Hirsch I, Chermann JC. Reply to F. Wong-Staal's comments in Methods in Molecular and Cellular Biology, Volume 2, Number 2, 1990, page 43 Methods in Molecular and Cellular Biology. 2: 97.  0.182
1990 Hirsch I, Spire B, Tsunetsugu-Yokota Y, Neuveut C, Sire J, Chermann JC. Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR). Virology. 177: 759-63. PMID 2371778 DOI: 10.1016/0042-6822(90)90544-2  0.439
1990 Spire B, Hirsch I, Neuveut C, Sire J, Chermann JC. The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant. Virology. 177: 756-8. PMID 2371777 DOI: 10.1016/0042-6822(90)90543-Z  0.402
1990 Chermann JC. HIV-associated diseases: acute and regressive encephalopathy in a seropositive man. Research in Virology. 141: 137-41. PMID 2345808 DOI: 10.1016/0923-2516(90)90015-B  0.472
1990 Devaux C, Boucraut J, Poirier G, Corbeau P, Rey F, Benkirane M, Perarnau B, Kourilsky F, Chermann JC. Anti-beta 2-microglobulin monoclonal antibodies mediate a delay in HIV1 cytopathic effect on MT4 cells. Research in Immunology. 141: 357-72. PMID 2267410 DOI: 10.1016/0923-2494(90)90026-U  0.344
1990 Honda M, Kitamura K, Mizutani Y, Oishi M, Arai M, Okura T, Igarahi K, Yasukawa K, Hirano T, Kishimoto T, Mitsuyasu R, Chermann JC, Tokunaga T. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases Journal of Immunology. 145: 4059-4064. PMID 2258606  0.288
1990 Tatsumi M, Jean F, Robert V, Chermann JC, Devaux C. Use of monoclonal antibodies for the detection and quantitation of HIV1 core protein p25: comparative evaluation of in vitro HIV1 infection by immunofluorescence, antigen capture ELISA and reverse transcriptase assays. Research in Virology. 141: 649-61. PMID 1708158 DOI: 10.1016/0923-2516(90)90037-J  0.42
1990 Schmidtmayerová H, Chermann JC, Rey F, Barré-Sinoussi F, Mayer V. Human immunodeficiency virus inhibition by lysed leukocyte ultrafiltrate. Acta Virologica. 34: 263-71. PMID 1703392  0.705
1990 Tatsumi M, Devaux C, Kourilsky F, Chermann JC. Characterization of monoclonal antibodies directed against distinct conserved epitopes of human immunodeficiency virus type 1 core proteins. Molecular and Cellular Biochemistry. 96: 127-36. PMID 1703272 DOI: 10.1007/BF00420904  0.426
1990 Ono K, Nakane H, Fukushima M, Chermann JC, Barré-Sinoussi F. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. European Journal of Biochemistry / Febs. 190: 469-76. PMID 1695572  0.687
1990 Ono K, Nakane H, Barre-Sinoussi F, Chermann JC. Differential inhibition by an antitumoral drug 10-[gamma-diethylaminopropylamino]-6-methyl-5H-pyrido[3',4': 4,5]pyrrolo [2,3-G]isoquinoline (BD-40), a pyrido-pyrrolo-isoquinoline derivative, of in vitro DNA synthesis catalyzed by various DNA polymerases. Cancer Letters. 51: 59-65. PMID 1692511 DOI: 10.1016/0304-3835(90)90231-L  0.618
1990 Corbeau P, Devaux C, Kourilsky F, Chermann JC. An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Journal of Virology. 64: 1459-64. PMID 1690821  0.375
1990 Ono K, Nakane H, Fukushima M, Chermann JC, Barré-Sinoussi F. Differential inhibition of the activities of reverse transcriptase and various cellular DNA polymerases by a traditional Kampo drug, sho-saiko-to. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 44: 13-6. PMID 1285436 DOI: 10.1016/0753-3322(90)90063-F  0.647
1990 Chermann JC. Human Immunodeficiency Virus (HIV) Transfusion Science. 11: S3-S7. DOI: 10.1016/0955-3886(90)90076-U  0.454
1990 Hirsch I, Sire J, Spire B, Hirsch MR, Zachar V, Chermann JC. Suppression of the chloramphenicol acetyltransferase (CAT) expression-silencer by human immunodeficiency virus type 1 (HIV-1)-derived tat product Methods in Molecular and Cellular Biology. 2: 1-4.  0.43
1989 Spire B, Sire J, Zachar V, Rey F, Barré-Sinoussi F, Galibert F, Hampe A, Chermann JC. Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus. Gene. 81: 275-84. PMID 2806917 DOI: 10.1016/0378-1119(89)90188-1  0.686
1989 Honda M, Kitamura K, Matsuda K, Yokota Y, Yamamoto N, Mitsuyasu R, Chermann JC, Tokunaga T. Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization. Journal of Immunology (Baltimore, Md. : 1950). 142: 4248-55. PMID 2566634  0.35
1989 Lunardi-Iskandar Y, Nugeyre MT, Georgoulias V, Barré-Sinoussi F, Jasmin C, Chermann JC. Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells. The Journal of Clinical Investigation. 83: 610-5. PMID 2563266 DOI: 10.1172/JCI113924  0.648
1989 Lescault A, Becker JL, Barre-Sinoussi F, Chermann JC, Best-Belpomme M, Ono K. Characterization of a reverse transcriptase activity associated with retrovirus-like particles in a Drosophila cell line. Cellular and Molecular Biology. 35: 163-71. PMID 2471594  0.648
1989 Ono K, Nakane H, Fukushima M, Chermann JC, Barré-Sinoussi F. Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone. Biochemical and Biophysical Research Communications. 160: 982-7. PMID 2471525 DOI: 10.1016/S0006-291X(89)80097-X  0.692
1988 Chermann JC. HIV: the etiologic agent of AIDS and associated diseases. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 42: 3-4. PMID 3408805  0.381
1988 Gout O, Rouquette B, Tournier-Lasserve E, Barre-Sinoussi F, Lyon-Caen O, Chermann JC. Acute and regressive encephalopathy coincident with transient isolation of human immunodeficiency virus from cerebrospinal fluid of a seropositive man. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 42: 15-9. PMID 3261605  0.722
1988 Krowka JF, Stites DP, Moss AR, Casavant CH, Carlson JR, Chermann JC, Barre-Sinoussi F, Rodgers RP, Bacchetti P, McHugh TM. Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco. Diagnostic and Clinical Immunology. 5: 381-7. PMID 3219786  0.679
1988 Chermann JC. [A reply to the doubts concerning the agent of AIDS]. Minerva Stomatologica. 37: XXX. PMID 2902512  0.261
1988 Becker JL, Barre-Sinoussi F, Dormont D, Best-Belpomme M, Chermann JC. RNA-dependent DNA polymerase activity is regulated by ecdysterone in a Drosophila cell line. Cellular and Molecular Biology. 34: 265-70. PMID 2463089  0.619
1988 Dormont D, Yeramian P, Lambert P, Spire B, Daveloose D, Barre-Sinoussi FC, Chermann JC. Cellular and molecular mechanisms of antiretroviral effects of HPA23. Cancer Detection and Prevention. 12: 181-94. PMID 2460236  0.701
1988 Ono K, Nakane H, Barré-Sinoussi F, Chermann JC. Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23). European Journal of Biochemistry / Febs. 176: 305-10. PMID 2458259  0.628
1988 Vittecoq D, Woerle R, Barre-Sinoussi F, Chermann JC. Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 42: 35-9. PMID 2457397  0.681
1988 Hénin Y, Maréchal V, Barré-Sinoussi F, Chermann JC, Morgenthaler JJ. Inactivation and partition of human immunodeficiency virus during Kistler and Nitschmann fractionation of human blood plasma. Vox Sanguinis. 54: 78-83. PMID 2453974  0.685
1988 Hénin Y, Maréchal V, Porrot F, Chermann JC. Inaktivierung des AIDS-Erregers HIV-1-Virus durch das Kontrazeptivum a-gen 53 n Laboratoriumsmedizin. 12: 246-248. DOI: 10.1515/labm.1988.12.6.246  0.421
1988 Pautrat G, Morel G, Dihl F, Allasia C, Rey F, Spire B, Sire J, Kourilsky F, Chermann JC. Polar distribution of viral particles on the cell surface of a lymphoid cell line in vitro infected with the virus HIV: Intracellular detection of the viral genome | DISTRIBUTION POLAIRE DES PARTICULES VIRALES A LA SURFACE DES CELLULES D'UNE LIGNEE LYMPHOCYTAIRE INFECTEES 'IN VITRO' PAR LE VIRUS HIV: DETECTION INTRACELLULAIRE DU GENOME VIRAL Retrovirus. 1: 17-24.  0.41
1987 Moss AR, Osmond D, Bacchetti P, Chermann JC, Barre-Sinoussi F, Carlson J. Risk factors for AIDS and HIV seropositivity in homosexual men. American Journal of Epidemiology. 125: 1035-47. PMID 3646828  0.681
1987 Rey F, Barré-Sinoussi F, Schmidtmayerova H, Chermann JC. Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells. Journal of Virological Methods. 16: 239-49. PMID 3477567 DOI: 10.1016/0166-0934(87)90008-5  0.71
1987 Lepers JP, De Saint Martin J, Chermann JC. HIV antibodies in Mauritania. Transactions of the Royal Society of Tropical Medicine and Hygiene. 81: 171-2. PMID 3445314  0.397
1987 Chermann JC, Barre-Sinoussi F. Role of the human immunodeficiency virus in the physiopathology of AIDS. Antibiotics and Chemotherapy. 38: 13-20. PMID 3310857  0.686
1987 Lunardi-Iskandar Y, Georgoulias V, Vittecoq D, Nugeyre MT, Ammar A, Clemenceau C, Barre-Sinoussi F, Chermann JC, Schwartzenberg L, Jasmin C. Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2. Leukemia Research. 11: 753-60. PMID 3114567 DOI: 10.1016/0145-2126(87)90013-0  0.653
1987 Vilmer E, Rhodes-Feuillette A, Rabian C, Benbunan M, Meletis J, Devergie A, Bourrhis JH, Gluckman JC, Chermann JC, Gluckman E. Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation. 44: 25-9. PMID 3111037  0.337
1987 Magasiny S, Spire B, Rey F, Barre-Sinoussi F, Chermann JC. Genetic comparison of LAV-related isolates. Cancer Detection and Prevention. Supplement : Official Publication of the International Society For Preventive Oncology, Inc. 1: 493-9. PMID 2826003  0.652
1987 Becker JL, Barre-Sinoussi F, Dormont D, Best-Belpomme M, Chermann JC. Characterization of the purified RNA dependent DNA polymerase isolated from Drosophila. Cellular and Molecular Biology. 33: 225-35. PMID 2440572  0.623
1987 Vittecoq D, Roue RT, Mayaud C, Borsa F, Armengaud M, Autran B, May T, Stern M, Chavanet P, Jeantils P, Modai J, Rey F, Chermann JC. ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS The Lancet. 329: 612-615. DOI: 10.1016/S0140-6736(87)90245-5  0.316
1987 Merlin M, Josse R, Gonzalez JP, Delaporte E, Dupont A, Salaun D, Georges-Courbot MC, Fleury H, Josserand R, Kouka Bemba D, McCormick JB, Limbassa J, Barre-Sinoussi F, Chermann JC, Georges AJ. Epidemiology of HIV1 infection among randomized representative Central African populations Annales De L'Institut Pasteur Virology. 138: 503-510.  0.359
1987 Rey F, Barre-Sinoussi F, Chermann JC. Biosynthesis of LAV gag gene products: Presence of an intracellular gag-pol precursor polyprotein Annales De L'Institut Pasteur Virology. 138: 161-168.  0.599
1986 Vilmer E, Rouzioux C, Barre F, Chermann JC, Gluckman JC, Devergie A, Montagnier L, Gluckman E. Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients New England Journal of Medicine. 314: 1252. PMID 3517641  0.499
1986 Ebbesen P, Melbye M, Jeffries DJ, Antonen J, Valle SL, Suni J, Ranki A, Krohn K, Chermann JC, Koch MA, Köhler H, Horváth A, Nagy K, Tóth FD, Füst G, et al. Seropositivity to LAV/HTLV-III in 11 European countries European Journal of Cancer and Clinical Oncology. 22: 1453-1456. PMID 3474150 DOI: 10.1016/0277-5379(86)90078-7  0.269
1986 Becker JL, Hazan U, Nugeyre MT, Rey F, Spire B, Barré-Sinoussi F, Georges A, Teulières L, Chermann JC. [Infection of insect cell lines by the HIV virus, an agent of AIDS, and a demonstration of insects of African origin infected by this virus]. Comptes Rendus De L'AcadéMie Des Sciences. SéRie Iii, Sciences De La Vie. 303: 303-6. PMID 3094848  0.715
1986 Barre-Sinoussi F, Chermann JC. The etiologic agent of AIDS. The Mount Sinai Journal of Medicine, New York. 53: 598-608. PMID 3027540  0.616
1986 Burger H, Weiser B, Robinson WS, Lifson J, Engleman E, Rouzioux C, Brun-Vézinet F, Barré-Sinoussi F, Montagnier L, Chermann JC. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. The American Journal of Medicine. 81: 5-10. PMID 3014878 DOI: 10.1016/0002-9343(86)90174-9  0.744
1986 Geroldi D, Aricò M, Plebani A, Maccario R, Notarangelo LD, Duse M, Rey F, Barrè Sinoussi F, Chermann JC, Burgio GR. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families. Infection. 14: 60-3. PMID 3011677 DOI: 10.1007/BF01644443  0.322
1986 Chassagne J, Verrelle P, Dionet C, Clavel F, Barre-Sinoussi F, Chermann JC, Montagnier L, Gluckman JC, Klatzmann D. A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. Journal of Immunology (Baltimore, Md. : 1950). 136: 1442-5. PMID 3003197  0.654
1986 Rey F, Salaun D, Lesbordes JL, Gadelle S, Ollivier-Henry F, Barré-Sinoussi F, Chermann JC, Georges AJ. HIV-I and HIV-II double infection in Central African Republic. Lancet (London, England). 2: 1391-2. PMID 2878244 DOI: 10.1016/S0140-6736(86)92027-1  0.679
1986 Vittecoq D, Autran B, Bourstyn E, Chermann JC. LYMPHADENOPATHY SYNDROME AND SEROCONVERSION TWO MONTHS AFTER SINGLE USE OF NEEDLE SHARED WITH AN AIDS PATIENT The Lancet. 327: 1280. PMID 2872425 DOI: 10.1016/S0140-6736(86)91423-6  0.28
1986 Magasiny S, Spire B, Barré-Sinoussi F, Chermann JC. Genomic variability of selected LAV-related AIDS retroviruses. Aids Research. 2: 19-30. PMID 2424466  0.681
1986 Achour A, Hazan U, Nugeyre M, Barré-Sinoussi F, Metezeau P, Gachelin H, Chapuis F, Klatzman D, Gluckman J, Goldberg M, Chermann J. A binding assay to identify HIV (LAV) target cells Annales De L'Institut Pasteur / Virologie. 137: 291-302. DOI: 10.1016/S0769-2617(86)80220-9  0.357
1986 Couroucé AM, Barin F, Baudelot J, Chermann JC, Chippaux A, Guéguen M, Janot C, Lemaire JM, Maniez M, Mesnier F, North ML, Rouzioux C, Smilovici W. Nouvelle évaluation de 3 trousses immunoenzymatiques de dépistage des anticorps anti-LAV Revue Francaise De Transfusion Et Immuno-Hematologie. 29: 97-100. DOI: 10.1016/S0338-4535(86)80025-3  0.226
1986 Chermann JC, Barre F, Montagnier L. Lymphadenopathy associated virus (LAV) as the primary etiologic agent of AIDS and therapeutic perspectives Tropical Medicine. 28: 115-116.  0.381
1985 Klatzmann D, Cavaille-Coll M, Brunet JB, Rozenbaum W, Kernbaum S, Barre-Sinoussi F, Chermann JC, Montagnier L, Gluckman JC. Immune status of AIDS patients in France: relationship with lymphadenopathy associated virus tropism. Annals of the New York Academy of Sciences. 437: 228-37. PMID 6335952 DOI: 10.1111/j.1749-6632.1984.tb37141.x  0.729
1985 Parravicini CL, Vago L, Costanzi GC, Gluckman JC, Klatzmann D, Berti E, Barre-Sinoussi F, Chermann JC, Lazzarin A, Moroni M. Immunohistochemical reactivity of anti-LAV p18 monoclonal antibody in lymph nodes from PGL and AIDS patients Bollettino Dell"Istituto Sieroterapico Milanese. 64: 422-424. PMID 3004544  0.354
1985 Burger H, Weiser B, Robinson WS, Lifson J, Engleman E, Rouzioux C, Brun-Vézinet F, Barré-Sinoussi F, Montagnier L, Chermann JC. Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. Annals of Internal Medicine. 103: 545-7. PMID 2994532 DOI: 10.7326/0003-4819-103-4-545  0.732
1985 Mathur-Wagh U, Mildvan D, Spigland I, Brun-Vezinet F, Barre-Sinoussi F, Montagnier L, Chermann JC. Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men Advances in Experimental Medicine and Biology. 187: 93-96. PMID 2994424  0.659
1985 Barré-Sinoussi F, Chermann JC. Lymphadenopathy associated virus (L.A.V.): its association with AIDS or prodromes. Advances in Experimental Medicine and Biology. 187: 35-43. PMID 2994418 DOI: 10.1007/978-1-4615-9430-7_3  0.652
1985 Aymard JP, Janot C, Chermann JC, Montagnier L, Briquel ME, Legras B, Alexandre P, Streiff F. Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs Vox Sanguinis. 49: 161-163. PMID 2994302  0.568
1985 Aymard JP, Janot C, Chermann JC, Briquel ME, Perrier P, Alexandre P, Streiff F. Prévalence des anticorps anti-LAV chez les hémophiles, corrélation avec l'état immunologique Revue Francaise De Transfusion Et Immuno-Hematologie. 28: 261-265. PMID 2994201 DOI: 10.1016/S0338-4535(85)80117-3  0.292
1985 Ziza JM, Brun-Vezinet F, Venet A, Rouzioux CH, Traversat J, Israel-Biet B, Barre-Sinoussi F, Chermann JC, Godeau P. Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis New England Journal of Medicine. 313: 183. PMID 2989685  0.661
1985 Kiprov DD, Anderson RE, Morand PR, Simpson DM, Chermann JC, Levy JA, Ross AR. Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS New England Journal of Medicine. 312: 1517. PMID 2985997 DOI: 10.1056/nejm198506063122312  0.284
1985 Barre-Sinoussi F, Mathur-Wagh U, Rey F, Brun-Vezinet F, Yancovitz SR, Rouzioux C, Montagnier L, Mildvan D, Chermann JC. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS Journal of the American Medical Association. 253: 1737-1739. PMID 2983130 DOI: 10.1001/jama.253.12.1737  0.751
1985 Barre-Sinoussi F, Nugeyre MT, Chermann JC. RESISTANCE OF AIDS VIRUS AT ROOM TEMPERATURE The Lancet. 326: 721-722. PMID 2863698 DOI: 10.1016/S0140-6736(85)92955-1  0.643
1985 Rozenbaum W, Dormont D, Spire B, Vilmer E, Gentilini M, Griscelli C, Montagnier L, Barre-Sinoussi F, Chermann JC. Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome Lancet. 1: 450-451. PMID 2857819 DOI: 10.1016/S0140-6736(85)91156-0  0.256
1985 Spire B, Barré-Sinoussi F, Dormont D, Montagnier L, Chermann JC. Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light Lancet. 1: 188-189. PMID 2857267 DOI: 10.1016/S0140-6736(85)92025-2  0.691
1985 Montagnier L, Clavel F, Krust B, Chamaret S, Rey F, Barré-sinoussi F, Chermann JC. Identification and antigenicity of the major envelope glycoprotein of of lymphadenopathy-associated virus Virology. 144: 283-289. PMID 2414918 DOI: 10.1016/0042-6822(85)90326-5  0.739
1985 Barré-Sinoussi F, Nugeyre MT, Girard M, Tron F, Chermann JC. LABORATORY AND SEROLOGICAL STUDIES ARGUE AGAINST POSSIBLE TRANSMISSION OF AIDS BY HEPATITIS B VACCINE The Lancet. 326: 274. PMID 2410750 DOI: 10.1016/S0140-6736(85)90319-8  0.599
1985 Dormont D, Spire B, Barré-Sinoussi F, Montagnier L, Chermann J. Inhibition of RNA-dependent DNA polymerases of AIDS and SAIDS retroviruses by HPA-23 (ammonium-21-tungsto-9-antimoniate) Annales De L'Institut Pasteur / Virologie. 136: 75-83. DOI: 10.1016/S0769-2617(85)80114-3  0.694
1985 Chermann J, Barre-Sinoussi F, Rozenbaum W. Le LAV/HTLV III comme agent étiologique du SIDA : revue et perspectives thérapeutiques MéDecine Et Maladies Infectieuses. 15: 505-508. DOI: 10.1016/S0399-077X(85)80055-X  0.593
1985 Robaut C, Rivalle C, Rautureau M, Lhoste JM, Bisagni E, Chermann JC. Synthese et etude de 5H-pyrido[4,3-b]-benzo[f]indoloquinones-6,11 apparentees aux ellipticines et aux anthracyclines Tetrahedron. 41: 1945-1951. DOI: 10.1016/S0040-4020(01)96558-5  0.191
1985 Bussereau F, Picard M, Gosselin O, Blancou J, Chermann J, Sureau P. Search for antiviral drugs against rabies virus infection Virus Research. 3: 86. DOI: 10.1016/0168-1702(85)90424-1  0.331
1984 Ono K, Nakane H, Souyri-Caporale M, Barré-Sinoussi F, Rey F, Jasmin C, Chermann JC. Induction of cellular DNA polymerases in a Burkitt lymphoma-derived cell line by treatment with 5-iododeoxyuridine. Biochemical and Biophysical Research Communications. 123: 1170-8. PMID 6385973 DOI: 10.1016/S0006-291X(84)80256-9  0.642
1984 Kalyanaraman VS, Cabradilla CD, Getchell JP, Narayanan R, Braff EH, Chermann JC, Barré-Sinoussi F, Montagnier L, Spira TJ, Kaplan J. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science (New York, N.Y.). 225: 321-3. PMID 6330889 DOI: 10.1126/science.6330889  0.733
1984 Feorino PM, Kalyanaraman VS, Haverkos HW, Cabradilla CD, Warfield DT, Jaffe HW, Harrison AK, Gottlieb MS, Goldfinger D, Chermann JC, Barré-Sinoussi F, Spira TT, McDougal JS, Curran JW, Montagnier L, et al. Lymphadenopathy associated virus infection of a blood donor-recipient pair with acquired immunodeficiency syndrome Science. 225: 69-72. PMID 6328663 DOI: 10.1126/science.6328663  0.378
1984 Montagnier L, Gruest J, Chamaret S, Dauguet C, Axler C, Guétard D, Nugeyre MT, Barré-Sinoussi F, Chermann JC, Brunet JB. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science (New York, N.Y.). 225: 63-6. PMID 6328661 DOI: 10.1126/science.6328661  0.733
1984 Klatzmann D, Barré-Sinoussi F, Nugeyre MT, Danquet C, Vilmer E, Griscelli C, Brun-Veziret F, Rouzioux C, Gluckman JC, Chermann JC. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science (New York, N.Y.). 225: 59-63. PMID 6328660 DOI: 10.1126/science.6328660  0.696
1984 Souyri-Caporale M, Tovey MG, Ono K, Jasmin C, Chermann JC. Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine. The Journal of General Virology. 831-5. PMID 6323625 DOI: 10.1099/0022-1317-65-4-831  0.352
1984 Crépin M, Lidereau R, Chermann JC, Pouillart P, Magdamenat H, Montagnier L. Sequences related to mouse mammary tumor virus genome in tumor cells and lymphocytes from patients with breast cancer. Biochemical and Biophysical Research Communications. 118: 324-31. PMID 6320830 DOI: 10.1016/0006-291X(84)91104-5  0.539
1984 Brun-Vézinet F, Rouzioux C, Montagnier L, Chamaret S, Gruest J, Barré-Sinoussi F, Geroldi D, Chermann JC, Mccormick J, Mitchell S, Piot P, Taelman H, Mirlangu KB, Wobin O, Mbendi N, et al. Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS Science. 226: 453-456. PMID 6238406 DOI: 10.1126/science.6238406  0.713
1984 Spire B, Barré-Sinoussi F, Montagnier L, Chermann JC. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet (London, England). 2: 899-901. PMID 6207400 DOI: 10.1016/S0140-6736(84)90657-3  0.714
1984 Chermann JC, Barré-Sinoussi F, Dauguet C, Brun-Vezinet F, Rouzioux C, Rozenbaum W, Montagnier L. Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. Antibiotics and Chemotherapy. 32: 48-53. PMID 6205626 DOI: 10.1159/000409704  0.702
1984 Rey MA, Spire B, Dormont D, Barre-Sinoussi F, Montagnier L, Chermann JC. Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochemical and Biophysical Research Communications. 121: 126-33. PMID 6203528 DOI: 10.1016/0006-291X(84)90696-X  0.723
1984 Melbye M, Biggar RJ, Chermann JC, Montagnier L, Stenbjerg S, Ebbesen P. High prevalence of lymphadenopathy virus (LAV) in European haemophiliacs. Lancet (London, England). 2: 40-1. PMID 6145955 DOI: 10.1016/S0140-6736(84)92023-3  0.554
1984 Brun-Vezinet F, Rouzioux C, Barre-Sinoussi F, Klatzmann D, Saimot AG, Rozenbaum W, Christol D, Gluckmann JC, Montagnier L, Chermann JC. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (London, England). 1: 1253-6. PMID 6144973 DOI: 10.1016/S0140-6736(84)92444-9  0.683
1984 Laurence J, Brun-Vezinet F, Schutzer SE, Rouzioux C, Klatzmann D, Barré-Sinoussi F, Chermann JC, Montagnier L. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. The New England Journal of Medicine. 311: 1269-73. PMID 6092953 DOI: 10.1056/NEJM198411153112001  0.749
1984 Montagnier L, Dauguet C, Axler C, Chamaret S, Gruest J, Nugeyre M, Rey F, Barré-Sinoussi F, Chermann J. A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: Structural and antigenic relatedness with equine infectious anaemia virus Annales De L'Institut Pasteur / Virologie. 135: 119-134. DOI: 10.1016/S0769-2617(84)80046-5  0.725
1983 Rivalle C, Wendling F, Tambourin P, Lhoste JM, Bisagni E, Chermann JC. Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications. Journal of Medicinal Chemistry. 26: 181-5. PMID 6827534 DOI: 10.1021/jm00356a012  0.213
1983 Herve M, Sinoussi-Barre F, Chermann JC, Herve G, Jasmin C. Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases. Biochemical and Biophysical Research Communications. 116: 222-9. PMID 6196027 DOI: 10.1016/0006-291X(83)90404-7  0.282
1982 Larnicol N, Augery Y, Le Bousse-Kerdiles C, Degiorgis V, Chermann JC, Teze A, Jasmin C. In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia. The Journal of General Virology. 55: 17-23. PMID 7299368 DOI: 10.1099/0022-1317-55-1-17  0.308
1982 Levy JA, Jakob H, Paulin D, Kelly F, Chermann JC, Jacob F. Productive infection of embryonal carcinoma cells with ecotropic mouse type C viruses and subsequent arrest of differentiation. Virology. 120: 157-70. PMID 6285595 DOI: 10.1016/0042-6822(82)90014-9  0.321
1981 Ducrocq C, Wendling F, Tourbez-Perrin M, Rivalle C, Tambourin P, Pochon F, Bisagni E, Chermann JC. Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives. Journal of Medicinal Chemistry. 23: 1212-6. PMID 7452670 DOI: 10.1021/jm00185a012  0.25
1981 Allard P, Dinh TH, Gouyette C, Igolen J, Chermann JC, Barré-Sinoussi F. 2-l-Rhamnopyranosyl[1,2,4]triazolo[1,5-a]pyridine. 4' and 3' Oxidation products. Synthesis and structure-activity relationships. Journal of Medicinal Chemistry. 24: 1291-7. PMID 6273559 DOI: 10.1021/jm00143a006  0.316
1980 Lawrence F, Chermann JC, Robert-Gero M. Metabolism of 5' deoxy-5'[35S]-isobutyl-thio-adenosine (SIBA) in rats and mice. Biochemical Pharmacology. 29: 1963-5. PMID 6967320 DOI: 10.1016/0006-2952(80)90111-2  0.177
1978 Tsiang H, Atanasiu P, Chermann JC, Jasmin C. Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate. The Journal of General Virology. 40: 665-8. PMID 690613 DOI: 10.1099/0022-1317-40-3-665  0.38
1978 Chermann JC, Sinoussi FC, Jasmin C. Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate. Biochemical and Biophysical Research Communications. 65: 1229-36. PMID 79415 DOI: 10.1016/S0006-291X(75)80361-5  0.273
1978 Ablashi DV, Twardzik DR, Easton JM, Armstrong GR, Luetzeler J, Jasmin C, Chermann JC. Effects of 5-tungsto-2-antimoniate in oncogenic DNA and RNA virus-cell systems. European Journal of Cancer. 13: 713-20. PMID 74337 DOI: 10.1016/0014-2964(77)90058-5  0.339
1976 Werner GH, Jasmin C, Chermann JC. Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice. The Journal of General Virology. 31: 59-64. PMID 177729 DOI: 10.1099/0022-1317-31-1-59  0.336
1976 Raybaud N, Chermann JC, Sinoussi FC, Augery Y, Jasmin C. Studies on the mechanism of action of ammonium-5-tungsto-2-antimoniate (HPA 23). Bibliotheca Haematologica. 504-7. PMID 61002 DOI: 10.1159/000399204  0.183
1974 Jasmin C, Chermann JC, Herve G, Teze A, Souchay P, Boy-Loustau C, Raybaud N, Sinoussi F, Raynaud M. In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate. Journal of the National Cancer Institute. 53: 469-74. PMID 4367244 DOI: 10.1093/jnci/53.2.469  0.336
1974 Jasmin C, Chermann JC, Raybaud N, Bucchini D, Jarrett O, Raynaud M, Mathé G, Plata F. Effects of STAS JLSV5 and silicotungstate on the replication of murine sarcoma virus (Moloney) and poliovirus. Bibliotheca Haematologica. 39: 381-8. PMID 4360170 DOI: 10.1159/000427866  0.376
1973 Raynaud M, Kouznetzova B, Navarro MJ, Chermann JC, Digeon M, Petitprez A. A common antigenic constituent in various purified Salmonella endotoxins. The Journal of Infectious Diseases. 128: 35-42. PMID 4198204 DOI: 10.1093/infdis/128.Supplement_1.S35  0.251
1972 Mendiola LR, Kouznetzova B, Chermann J, Sinoussi F, Digeon M, Raynaud M. Purification of Bacterial Endotoxins by Zonal Centrifugation Infection and Immunity. 6: 27-31. DOI: 10.1128/iai.6.1.27-31.1972  0.171
Show low-probability matches.